Impact of eptifibatide on early ischemic events in acute ischemic coronary syndromes: a review of the IMPACT II trial. Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis.

Tcheng, J E

Impact of eptifibatide on early ischemic events in acute ischemic coronary syndromes: a review of the IMPACT II trial. Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis. [electronic resource] - The American journal of cardiology Aug 1997 - 21B-28B p. digital

Publication Type: Journal Article; Review

0002-9149

10.1016/s0002-9149(97)00573-0 doi


Clinical Trials, Phase III as Topic
Drug Administration Schedule
Eptifibatide
Humans
Myocardial Ischemia--mortality
Peptides--therapeutic use
Platelet Aggregation Inhibitors--therapeutic use
Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors
Randomized Controlled Trials as Topic
Survival Analysis
Treatment Outcome